Eloralintide
Investigational amylin-receptor medicine in clinical trials. Not FDA-approved.
- Type
- Investigational medicine
- Research area
- Metabolic research
- Research stage
- Clinical trials
- FDA status
- Not an FDA-approved medicine
About Eloralintide
Investigational amylin-receptor medicine in clinical trials. Not FDA-approved.
Where the research stands
Most published work on this compound comes from laboratory, animal or early human studies. Results in those settings don't always carry over to people, and long-term safety data are limited.
Read the studies
Educational information only; not medical advice. Talk to a licensed doctor before using any compound.
Common questions
Is Eloralintide an FDA-approved medicine?
No. Eloralintide is not an FDA-approved medicine. Research stage: Clinical trials.
Does EKO Labs sell Eloralintide?
No. EKO Labs does not sell Eloralintide or any research compound. This library is for education only. EKO Labs offers FDA-approved prescription treatments only after a licensed doctor decides they are right for you.
Can people use Eloralintide?
This page does not cover personal use. Products labeled "research use only" are not made or approved for people. Ask a licensed doctor before using any compound.
What is the molecular formula of Eloralintide?
According to PubChem (U.S. National Library of Medicine), Eloralintide has the molecular formula C201H319N49O65S2 and a molar mass of about 4,526.0 g/mol.
The molecule: Eloralintide
Drag to rotate. Every atom and bond below comes from the public PubChem database of the U.S. National Institutes of Health; nothing is drawn by AI.
- Formula
- C201H319N49O65S2
- Molar mass
- 4,526.0 g/mol
- Heavy atoms
- 317
- PubChem CID
- 175663130 ↗
Source: PubChem, National Library of Medicine (public domain).
Related compounds
C194H312N54O59S2CagriSemaCagriSema
Investigational combination of cagrilintide and semaglutide in clinical trials. Not FDA-approved.
C17H23Cl2NOTesofensineTesofensine
Studied in clinical research; not approved in the United States.
RetatrutideRetatrutide
Investigational triple-agonist medicine in clinical trials. Not FDA-approved.